Agenda
- Challenges and implications of measuring financial instruments under IFRS 13
- Review of the different Fair Value Adjustements – CVA/ DVA/ FVA
- Risk factors and requirements for calculating CVA, DVA & FVA (XVA)
Presenters
- Dr. Dmitry Pugachevsky, Director of Research, Quantifi
- Dr. Roman Bedau, Consultant, Deloitte
“A comprehensive evaluation of bilateral CVA needs to take into account the time dependent dynamics of the derivatives’ market values as well as an estimate for the probability of default of both contractual partners.”
Dr. Roman Bedau, Consultant, Deloitte